Alternative Names
Anti-GM-CSFR monoclonal antibody research-grade biosimilar; CAM3001 research-grade biosimilar; CAM-3001 research-grade biosimilar; GM-CSFR research-grade biosimilar; GM-CSFRa research-grade biosimilar; KPL-301 research-grade biosimilar; Mavrilimumab research-grade biosimilar; Mavrilimumab (USAN/INN) research-grade biosimilar; CSF2RA antibody; CSF2R antibody; CSF2RY antibody;Granulocyte-macrophage colony-stimulating factor receptor subunit alpha antibody; GM-CSF-R-alpha antibody; GMCSFR-alpha antibody; GMR-alpha antibody; CDw116 antibody; CD antigen CD116 antibody
Immunogen
Recombinant Human CSF2RA protein
Immunogen Species
Homo sapiens (Human)
Concentration
It differs from different batches. Please contact us to confirm it.
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.